Loading the section
Closing prices for 09 October 2026
Next earnings report: none scheduled in the next five weeks · Earnings calendar
The series is stated in the current share scale after splits; dividends are not included in the price
Neogen Corporation trades on Nasdaq under the ticker NEOG. The company belongs to the Health care sector. The trading history on this page starts on 22 August 2016.
Over the past 52 weeks NEOG has traded between 5.37 $ and 14.26 $. As of 09 October 2026 the price stood 72.89 % of the way from the 52-week low to the high.
Over one year NEOG shares rose 103.61 %; over six months they rose 25.80 %. Volatility over 90 days is 53.95 %. Dividends are not included: this is price change only, as of 09 October 2026.
The company reported a loss over the last four quarters, so a price-to-earnings ratio is not calculated. Price to sales is 3.0, below the sector median of 3.9. Price to book is 1.3, below the sector median of 2.4. Calculated from reports for the period ending 28 February 2026.
| Date | Open | High | Low | Close | Volume, shares |
|---|---|---|---|---|---|
| 09 October 2026 | 11.71 | 12.11 | 11.57 | 11.85 | 4M |
| 08 October 2026 | 11.50 | 12.21 | 11.13 | 11.71 | 9M |
| 07 October 2026 | 12.61 | 12.93 | 11.37 | 11.68 | 13M |
| 06 October 2026 | 13.06 | 13.22 |
Based on the last 12 months of reports, through 28 February 2026
The sector median covers every company in the sector on the US market, loss-making ones included.
Neogen Corporation (NEOG) is a public company in the healthcare sector. Its common stock trade on NASDAQ.
Over the trailing twelve months as reported to 2025-05-31, revenue was 894.7m $, net income was -1.1bn $. Incorporated in US.
This summary is compiled automatically from SEC filings and exchange data.
Address:620 LESHER PLACE, LANSING, MI, 48912, US
Neogen Corporation reported revenue of 871M $ and a net loss of 609M $ over the last four quarters. Net margin is −69.93 %. Revenue changed by −3.91 % year over year. Earnings per share are −2.80 $. Market capitalisation is 2.6B $.
NEOG has a return on equity of −28.96 %, above the sector median of −41.68 %. Return on assets is −18.12 %, above the sector median of −32.11 %. Operating margin is −73.04 %, below the sector median of −26.84 %.
| 60M |
| QDELQuidelOrtho Corporation | 13.42 | +8.14 % | 20M |
| ACHVAchieve Life Sciences, Inc. | 7.39 | +2.78 % | 12M |
| QCLSQ/C Technologies, Inc. | 0.6300 | −1.10 % | 10M |
| MYGNMyriad Genetics, Inc. | 4.31 | +2.62 % | 8M |
| 11.86 |
| 11.96 |
| 6M |
| 05 October 2026 | 12.02 | 13.06 | 11.98 | 13.01 | 5M |
| 02 October 2026 | 12.40 | 12.50 | 12.13 | 12.15 | 3M |
| 01 October 2026 | 12.68 | 12.82 | 12.19 | 12.24 | 3M |
| 30 September 2026 | 12.58 | 13.11 | 12.51 | 12.80 | 7M |
| 29 September 2026 | 13.74 | 13.87 | 12.71 | 12.73 | 15M |
| 28 September 2026 | 13.75 | 13.85 | 13.42 | 13.72 | 8M |
| 25 September 2026 | 13.68 | 13.86 | 13.38 | 13.76 | 5M |
| 24 September 2026 | 13.48 | 14.01 | 13.46 | 13.66 | 4M |
| 23 September 2026 | 14.21 | 14.26 | 13.50 | 13.57 | 4M |
| 22 September 2026 | 13.62 | 14.18 | 13.61 | 13.98 | 5M |
| 21 September 2026 | 13.12 | 13.72 | 12.96 | 13.61 | 4M |
| 18 September 2026 | 12.75 | 13.07 | 12.71 | 13.00 | 7M |
| 17 September 2026 | 12.75 | 13.00 | 12.61 | 12.83 | 4M |
| 16 September 2026 | 12.30 | 12.91 | 12.30 | 12.55 | 3M |
| 15 September 2026 | 11.95 | 12.37 | 11.85 | 12.25 | 3M |
| 14 September 2026 | 11.68 | 11.97 | 11.67 | 11.95 | 2M |